NYSE: HUM | Healthcare / Healthcare Plans / USA |
484.87 | -28.41 | -5.53% | Vol 1.52M | 1Y Perf 27.93% |
Feb 2nd, 2023 13:03 DELAYED |
BID | 484.77 | ASK | 485.44 | ||
Open | 499.13 | Previous Close | 513.28 | ||
Pre-Market | 501.66 | After-Market | - | ||
-11.62 -2.26% | - - |
Target Price | 602.61 | Analyst Rating | Strong Buy 1.31 | |
Potential % | 23.96 | Finscreener Ranking | ★★★ 49.86 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★ 45.98 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★★ 59.87 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | ★+ 35.24 | |
Price Range Ratio 52W % | 53.76 | Earnings Rating | Strong Sell | |
Market Cap | 61.38B | Earnings Date | 1st Feb 2023 | |
Alpha | 0.01 | Standard Deviation | 0.08 | |
Beta | 0.80 |
Today's Price Range 483.41506.51 | 52W Range 384.39571.30 | 5 Year PE Ratio Range 10.4065.20 |
Summary:
Buy
Technical Indicators: | Neutral |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 2.79% | ||
1 Month | 0.21% | ||
3 Months | -8.27% | ||
6 Months | 7.29% | ||
1 Year | 27.93% | ||
3 Years | 52.65% | ||
5 Years | 85.63% | ||
10 Years | 599.05% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 15.15 | |||
ROE last 12 Months | 18.70 | |||
ROA (5Y Avg) | 4.20 | |||
ROA last 12 Months | 6.30 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | - | |||
Return on invested Capital Q | - | |||
Return on invested Capital Y | - | |||
Assets Turnover | 1.60 | |||
Receivables Turnover | - |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
22.30 | ||||
3.84 | ||||
0.87 | ||||
6.50 | ||||
5.70 | ||||
75.24 | ||||
11.63 | ||||
128.39 | ||||
59.63B | ||||
Forward PE | 17.33 | |||
PEG | 1.58 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
0.32 | ||||
0.67 | ||||
10.30 | ||||
Leverage Ratio | 3.10 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
4.30 | ||||
- | ||||
4.40 | ||||
4.00 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
70.43B | ||||
556.33 | ||||
11.84 | ||||
10.13 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.65 | ||||
3.15 | ||||
10.60 | ||||
13.72 | ||||
Payout ratio | 9.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q04 2022 | 1.46 | 1.62 | 10.96 |
Q03 2022 | 6.25 | 6.88 | 10.08 |
Q02 2022 | 7.67 | 8.67 | 13.04 |
Q01 2022 | 6.83 | 8.04 | 17.72 |
Q04 2021 | 1.23 | 1.24 | 0.81 |
Q03 2021 | 4.61 | 4.83 | 4.77 |
Q02 2021 | 6.86 | 6.89 | 0.44 |
Q01 2021 | 7.21 | 7.67 | 6.38 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2022 QR | 1.47 | -31.94 | Negative |
12/2022 FY | 25.05 | 0.16 | Positive |
3/2023 QR | 8.52 | -2.18 | Negative |
12/2023 FY | 27.97 | 0.00 | - |
Next Report Date | - |
Estimated EPS Next Report | 1.46 |
Estimates Count | 9 |
EPS Growth Next 5 Years % | 14.10 |
Volume Overview | |
---|---|
Volume | 1.52M |
Shares Outstanding | 126.60K |
Shares Float | 126.27M |
Trades Count | 35.48K |
Dollar Volume | 749.88M |
Avg. Volume | 1.25M |
Avg. Weekly Volume | 1.58M |
Avg. Monthly Volume | 1.15M |
Avg. Quarterly Volume | 1.03M |
Humana Inc. (NYSE: HUM) stock closed at 513.28 per share at the end of the most recent trading day (a 0.31% change compared to the prior day closing price) with a volume of 1.91M shares and market capitalization of 61.38B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 48700 people. Humana Inc. CEO is Bruce D. Broussard.
The one-year performance of Humana Inc. stock is 27.93%, while year-to-date (YTD) performance is 0.21%. HUM stock has a five-year performance of 85.63%. Its 52-week range is between 384.385 and 571.3, which gives HUM stock a 52-week price range ratio of 53.76%
Humana Inc. currently has a PE ratio of 22.30, a price-to-book (PB) ratio of 3.84, a price-to-sale (PS) ratio of 0.87, a price to cashflow ratio of 6.50, a PEG ratio of 2.32, a ROA of 6.30%, a ROC of -% and a ROE of 18.70%. The company’s profit margin is 4.00%, its EBITDA margin is -%, and its revenue ttm is $70.43 Billion , which makes it $556.33 revenue per share.
Of the last four earnings reports from Humana Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.46 for the next earnings report. Humana Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Humana Inc. is Strong Buy (1.31), with a target price of $602.61, which is +23.96% compared to the current price. The earnings rating for Humana Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Humana Inc. has a dividend yield of 0.65% with a dividend per share of $3.15 and a payout ratio of 9.00%.
Humana Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 9.20, ATR14 : 13.92, CCI20 : 222.88, Chaikin Money Flow : -0.04, MACD : -2.23, Money Flow Index : 77.25, ROC : 4.46, RSI : 57.38, STOCH (14,3) : 69.49, STOCH RSI : 1.00, UO : 49.15, Williams %R : -30.51), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Humana Inc. in the last 12-months were: Bruce D. Broussard (Option Excercise at a value of $13 670 312), Bruce D. Broussard (Sold 16 000 shares of value $8 819 004 ), Cynthia H. Zipperle (Option Excercise at a value of $0), David A. Jones (Sold 15 000 shares of value $7 525 800 ), Heather M. Carroll Cox (Option Excercise at a value of $0), Jorge S. Mesquita (Option Excercise at a value of $0), Joseph C. Ventura (Option Excercise at a value of $1 106 210), Joseph C. Ventura (Sold 4 381 shares of value $2 404 755 ), Marcy S. Klevorn (Option Excercise at a value of $0), Samir Deshpande (Option Excercise at a value of $2 736 953), Samir Deshpande (Sold 11 919 shares of value $6 224 217 ), Susan D. Schick (Option Excercise at a value of $0), Susan M. Diamond (Option Excercise at a value of $1 422 797), Susan M. Diamond (Sold 5 623 shares of value $3 184 030 ), Timothy Alan Wheatley (Option Excercise at a value of $5 195 662), Timothy Alan Wheatley (Sold 22 570 shares of value $12 779 377 ), Timothy S. Huval (Option Excercise at a value of $2 578 540), Timothy S. Huval (Sold 11 549 shares of value $5 616 284 ), Vishal Agrawal (Option Excercise at a value of $0), William H Shrank (Option Excercise at a value of $0), William Kevin Fleming (Option Excercise at a value of $3 619 973), William Kevin Fleming (Sold 14 367 shares of value $7 754 021 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
CEO: Bruce D. Broussard
Telephone: +1 502 580-1000
Address: 500 West Main Street, Louisville 40202, KY, US
Number of employees: 48 700
Thu, 02 Feb 2023 15:25 GMT Humana (HUM) Receives a Rating Update from a Top Analyst
- TipRanks. All rights reserved.Mon, 30 Jan 2023 12:18 GMT Humanas (HUM) New Defense Contract Extension Could Be Worth $16.26B
- TipRanks. All rights reserved.Thu, 03 Nov 2022 12:42 GMT Analysts Offer Insights on Healthcare Companies: Humana (HUM), Premier (PINC) and Bausch + Lomb Corporation (BLCO)
- TipRanks. All rights reserved.Mon, 19 Sep 2022 04:30 GMT Analysts Offer Insights on Healthcare Companies: Humana (HUM), Innate Pharma (IPHA) and scPharmaceuticals (SCPH)
- TipRanks. All rights reserved.Sat, 30 Jul 2022 01:50 GMT RBC Capital Believes Humana (HUM) Wont Stop Here
- TipRanks. All rights reserved.Thu, 28 Jul 2022 12:15 GMT Analysts Offer Insights on Healthcare Companies: Amedisys (AMED), Humana (HUM) and Teladoc (TDOC)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.